Newsroom

Official news releases and announcements from organizations worldwide, distributed by EZ Newswire.

November 19, 2026 5:10 PM
EDT
•
WASHINGTON, DC

Securiport Implements APIS Plus, a Unique Advance Passenger Information System Integrating Its Technology Used in the European Union

WASHINGTON, DC, November 19, 2026 (EZ Newswire) -- Securiport, a U.S.-based civil aviation security and border control company, today announced APIS Plus, a unique advance passenger information system built on the company’s proprietary, patented technology.

Securiport has developed its core technology in-house over more than two decades, backed by 20+ patents and proprietary trade secrets. APIS Plus brings that technology together in a single system to ensure border authorities are equipped with smart border technology systems to process passenger lists in advance. They can verify identities, assess risk, and act on warnings in one place.

APIS Plus includes:

  • Multimodal biometric identification: Facial, fingerprint, and iris recognition confirm that the person at the border is the traveler whose data the airline sent ahead.
  • Intelligent risk analysis: Securiport’s proprietary data-analysis methods build risk profiles and give officers early warning of possible local and transnational criminal activity.
  • Near-real-time threat detection: Big data tools model, detect, and assess threats as passenger data arrives for officers to see a single picture of everyone crossing the border.
  • Data protection by design: Securiport’s information-handling methods assure governments that their data is localized and completely managed by the authorities.

APIS Plus connects border authorities directly with airlines, shipping lines, and other transport companies. Carriers upload passenger manifests through a secure gateway, and the system checks traveler information against national watchlists and Interpol databases, alerting officers to potential risks before arrival.

APIS Plus also offers:

  • Intuitive interface: A modern, familiar single-window interface serves Passenger Information Unit (PIU) analysts, transport company compliance users, and other stakeholders.
  • Guided analytics: Built-in tools help analysts visualize data, quickly find issues, anomalies, and alerts, and spot patterns in large data sets.
  • Ecosystem integration: Built-in connectors link APIS Plus with border control entry and exit systems and external risk assessment tools, giving visibility beyond the scope of standard PAXLST and PNRGOV passenger data messages.
  • All modalities: The system supports air, sea, and land travel, for large and small transport companies, private operators, and atypical use cases.

Securiport technology has been used in various regions including in the European Union and in South America. In keeping with confidentiality agreements with its government clients, the company does not disclose the specific agencies or countries involved.

Advance passenger information is an international standard for border management with the International Civil Aviation Organization requiring member states to operate API systems, and the United Nations Security Council Resolution 2396 calls on countries to collect API and Passenger Name Record (PNR) data to detect the movement of terrorists and other serious offenders.

“Our technology is unique. We built it in-house and proved it in some of the most demanding border environments in the world, including the European Union,” said Dr. Enrique Segura, president and CEO of Securiport. “APIS Plus gives governments a single platform that knows who is coming, confirms who has arrived, and flags risk in real time.”

“Global border authorities set a very high bar for security and data protection,” said Nate Carpenter, chief technology officer of Securiport. “Our technology has met that bar for years. APIS Plus builds on that experience, and governments keep full control of their data at every step.”

Governments and border agencies can learn more about APIS Plus at securiport.com/apis-plus.

About Securiport

Founded in 2001, Securiport is a privately owned, U.S.-based provider of civil aviation security and intelligent border control solutions. The company combines multimodal biometrics, advanced passenger information analysis and rules-based risk targeting to help governments keep travelers safe and borders secure. Securiport has exclusive and proprietary technology and maintains ISO 27001, ISO 27701and ISO 37001 certifications. Learn more at securiport.com.

Media Contact

Rahel Getachew
Director, Marketing and Communications
rgetachew@securiport.com
+1 202-333-0159

November 19, 2026 5:06 PM
EDT
•
SALT LAKE CITY, UT

Blotato Founder Sabrina Ramonov Featured in Tony Robbins' New Book 'The AI Advantage'

SALT LAKE CITY, UT, November 19, 2026 (EZ Newswire) -- Sabrina Ramonov, founder of Blotato, is one of the people profiled in "The AI Advantage: How Ordinary People Are Using AI to Build Extraordinary Lives," the new book from Tony Robbins and Dean Graziosi. The book releases Dec. 15, 2026, in hardcover, e-book, and audio. For the book, Robbins and Graziosi interviewed more than 50 people getting results with AI. Ramonov shared the news, and her content system, in a post about the book profile.

The book's public profile card describes Ramonov as a solo entrepreneur who went "from $0 to millions in annual revenue, with no team, no investors, and no paid ads."

Ramonov has more than 3 million followers and more than 33 million organic views a month across platforms. She has said her accounts kept pulling those monthly views through back-to-back vacations since May 2026. She works from a small stack of ideas and reshapes each one for each platform. Her accounts publish more than 250 posts a week.

"The AI Advantage" is one of three books featuring her work this year, along with HubSpot's "Loop" and "Smart AI for Small Business." HubSpot also built a section of its Inbound keynote around her content system, as the worked example for the framework in "Loop." In November 2025, she was on the AI Advantage Summit speaker lineup with Robbins and Graziosi.

In her post, Ramonov argues that an AI that writes content is only as useful as the access it is given. At 250 posts a week, she writes, an AI that only writes would leave someone pasting about 36 posts a day into separate apps.

Blotato is built to give an AI agent that access. It connects agents such as Claude and ChatGPT to accounts on nine social platforms through a hosted Model Context Protocol (MCP) server, the official ChatGPT plugin, or the official Claude connector, so the agent can schedule and publish posts directly. Blotato also handles direct messages and keyword-triggered DM automations on Instagram and Facebook. The free trial excludes API and MCP access, so creators who connect their AI agent to Blotato through the API or MCP server need a paid plan.

Ramonov uses Blotato to publish to her own accounts and run her DM automations. "I built Blotato so that 'content' doesn't own my life," she wrote in a Nov. 13 Substack post.

About Blotato

Blotato is the agent infrastructure for social media marketing. Through one API and MCP server, an AI agent like Claude or ChatGPT can schedule and publish posts on nine social platforms. The same connection lets it auto-reply to comments and DMs on Instagram and Facebook. Creators and small businesses schedule posts and set up those automations in the Blotato web app.

About Sabrina Ramonov

Sabrina Ramonov is the founder of Blotato and an AI educator for entrepreneurs, with over 3 million followers and 33 million monthly organic views. A Forbes 30 Under 30 honoree who sold her previous AI startup, Qurious.io, to Pegasystems, she now personally distributes over 250 pieces of content each week using Claude Code and Blotato, and is on a mission to teach 10 million people to use AI for free. Follow her on YouTube.

Media Contact

Sabrina Ramonov
Founder, Blotato
seo@blotato.com

November 19, 2026 2:31 PM
EDT
•
ZUG, Switzerland

WhiteBIT Turns Eight: From a Crypto Exchange to a Global Ecosystem Serving 40 Million Users

ZUG, Switzerland, November 19, 2026 (EZ Newswire) -- What started eight years ago as a cryptocurrency exchange has evolved into an international business ecosystem of 11 companies serving approximately 40 million registered users worldwide across its ecosystem, including 10 million on the WhiteBIT exchange. As WhiteBIT celebrates its eighth anniversary and W Group marks its first year, the milestones highlight a transformation from a single trading platform into a diversified business connecting traditional finance, digital assets and emerging technologies.

The scale of this growth is reflected in WhiteBIT's $2.8 trillion in combined spot and derivatives trading volume in 2026 and more than 5,500 institutional clients across the ecosystem. Meanwhile, W Group has expanded from eight to 11 companies in one year, growing its combined user base from 35 million to approximately 40 million.

From one exchange to a global business ecosystem

Established in 2025, W Group brought together businesses developed around WhiteBIT under a broader strategy: connecting traditional finance and digital assets while extending their applications into new industries.

The group aims to build more than a portfolio of independent companies. By combining financial infrastructure, technology and expertise, its businesses can develop new services, reach new markets and create opportunities across industries.

In 2026, W Group expanded well beyond financial services. Dutch sports car manufacturer Spyker joined the group in June, opening opportunities to apply digital finance and blockchain technology to luxury automotive.

W Group has also made a $400 million investment commitment in SignSplit, the signed-data platform for the AI era. The seed round values SignSplit at $1 billion.

In banking, Georgia-based hashbank licensed by the National Bank of Georgia, a fully licensed digital bank, combines traditional banking services with cryptocurrency functionality, allowing customers to manage fiat and digital assets within one environment.

Together, these businesses illustrate W Group's strategy of connecting financial services, technology and consumer-facing products into an ecosystem where each company can contribute to the growth of the others.

WhiteBIT at Eight: Expanding Global Trading

WhiteBIT remains a central pillar of W Group, providing trading infrastructure and digital asset services for retail and institutional clients.

In 2026, the exchange recorded $2.8 trillion in trading volume, with derivatives generating approximately $3.5 billion in daily activity. Its platform now offers nearly 1,200 trading markets.

Trading conditions have also improved. Spot trading volume across WhiteBIT's flagship BTC, ETH and WBT pairs increased more than fivefold, from $53 billion in 2020 to $276 billion in 2025. Meanwhile, bid-ask spreads across its major markets have narrowed approximately threefold since 2021, reflecting deeper liquidity.

WhiteBIT also serves more than 5,500 institutional clients, including funds, brokers and payment providers, through over 20 dedicated products and services. Businesses can access crypto liquidity, manage digital asset transactions and move between fiat currencies and cryptocurrencies through a single platform.

A landmark year for regulatory expansion

WhiteBIT's eighth year brought significant regulatory milestones that strengthen the group's international presence.

In June 2026, WhiteBIT EU secured authorisation under the EU's Markets in Crypto-Assets Regulation (MiCA) from Austria's Financial Market Authority, establishing a regulatory foundation for providing crypto-asset services across the European Union.

In May, WhiteBIT launched a dedicated platform for users in the United Kingdom, expanding into another major financial market with demanding regulatory requirements. The company also joined Ghana's regulatory sandbox in March, contributing to the development of the country's digital asset regulatory framework.

These developments reflect WhiteBIT's investment in compliance as a foundation for sustainable international growth.

WBT and a New Blockchain Chapter

The growth of the ecosystem is also reflected in WBT, WhiteBIT's native coin, which reached an all-time high of nearly $88 in September 2026, up from its launch price of $1.62 in 2022.*The milestone reflects WBT's strong long-term performance alongside the expansion of WhiteBIT and its ecosystem.

WBT's role is also expanding beyond trading. In November, Whitechain transitioned into an Ethereum Layer 2 network built on the OP Stack in partnership with Optimism, with WBT used to pay transaction fees. Designed to support blockchain applications and financial services, Whitechain has already attracted interest from developers, with more than 140 teams applying to its Builders Program ahead of the network's public launch planned for later in November.

Building the next generation of financial services

For W Group, the next stage of growth will focus on connecting its businesses more closely and turning their combined capabilities into new products and services.

"Eight years ago, we started with one cryptocurrency exchange. Today, we've grown into an international group of 11 companies serving around 40 million users. But our ambition has never been simply to build more businesses. We want to connect them in ways that create real value — bringing traditional finance and digital assets closer together, making new technologies more accessible and opening opportunities across industries," said Volodymyr Nosov, founder and president of W Group.

Looking ahead, W Group aims to strengthen its presence in regulated markets, expand institutional financial services and accelerate blockchain infrastructure development. Its long-term vision is an interconnected ecosystem where banking, payments, digital assets and emerging technologies work together, making financial services more accessible to people and businesses worldwide.

About WhiteBIT

WhiteBIT is a leading global crypto exchange by user traffic, offering over 1,020 trading pairs, more than 370 assets, and supporting eight fiat currencies. With a strong focus on regulatory compliance, WhiteBIT serves 10 million users across six continents and more than 150 countries. Founded in 2018, the platform is part of W Group, which has more than 40 million customers globally. WhiteBIT collaborates with Visa, FACEIT, FC Barcelona, Juventus FC, and the Ukrainian national football team. The company is dedicated to driving the widespread adoption of blockchain technology worldwide.

Risk Disclosure & Forward-Looking Statements

This announcement is for informational purposes only and does not constitute investment advice or an offer to buy or sell any digital asset. *Past performance (including WBT token pricing) is not indicative of future results; digital assets are highly volatile and carry a high risk of financial loss. Trading volumes and user metrics reflect internal company data. Statements regarding future ecosystem expansion, investments, and upcoming launches — including the public rollout of Whitechain — are forward-looking and subject to regulatory approvals, market conditions, and change without notice. Services are subject to jurisdictional eligibility and local regulations.

Media Contact

WhiteBIT PR
pr@whitebit.com

November 19, 2026 11:00 AM
EDT
•
DUBAI, United Arab Emirates

Octane.Rent Wins Two World Luxury Travel Awards 2026 as the Dubai Luxury Car Rental Company Expands to Miami

DUBAI, United Arab Emirates, November 19, 2026 (EZ Newswire) -- Octane.Rent, a luxury and sports car rental company headquartered in Dubai, has been named winner in two categories at the World Luxury Travel Awards 2026: Best Luxury Car Rental Company in the Middle East and Best Sports Car Rentals in the United Arab Emirates. The company operates more than 400 vehicles in the UAE, including luxury, sports, and electric models, and opened its first international location, in Brickell, Miami, this year.

What Did Octane.Rent Win in 2026?

Octane.Rent won two World Luxury Travel Awards 2026 titles: Best Luxury Car Rental Company in the Middle East and Best Sports Car Rentals in the United Arab Emirates. The Dubai-based company also holds a 2025 regional award. The official winner listing of the sixth annual World Luxury Travel Awards shows Octane Luxury Car Rental in the Luxury Car Rental Company category at continent level and in the Sports Car Rentals category at country level, and the organizer's establishment page lists Octane.Rent as a 2026 Continent Winner.

  • Award: World Luxury Travel Awards 2026: Best Luxury Car Rental Company in the Middle East; Best Sports Car Rentals in the United Arab Emirates
  • Previous recognition: 2025 regional award
  • Fleet: More than 400 vehicles in the UAE, including luxury, sports, and electric models
  • Locations: Dubai, Abu Dhabi, Sharjah, and, since 2026, Brickell in Miami

The awards, now in their sixth annual edition, recognize companies across luxury travel and hospitality, from hotels and tour operators to car rental firms. The 2026 result extends a record that began a year earlier, when Octane.Rent won a regional award.

How Do the World Luxury Travel Awards Choose Winners?

The World Luxury Travel Awards choose winners through nominations and online voting. Guests, travel agents, and tour operators nominate establishments, voters cast one vote per email address for each establishment, and companies compete only within their own category at country, regional, continent, and global level. Gala ceremonies confirm official winners.

The nomination criteria include service, attention to detail, facilities, customer reviews, and local knowledge. The organizers state that voting is based on the experience as a whole, together with service excellence, attention to detail, and efficiency, and that the size of an establishment is not considered in nomination or voting.

Best Luxury Car Rental in the Middle East and Best Sports Car Rentals in the UAE

Octane.Rent won Best Luxury Car Rental Company in the Middle East, a category that compares rental businesses across the region, and Best Sports Car Rentals in the United Arab Emirates, which compares performance car rentals in the country.

The regional title measures Octane.Rent against rental businesses in a region that includes some of the most active luxury travel destinations in the world. The national title focuses on performance cars in the country where Octane.Rent began operations and where visitors and residents rent supercars for city driving, coastal routes, and special occasions.

Octane.Rent rents luxury, sports, and electric vehicles by the day, week, or month and serves tourists, residents, corporate clients, and event organizers.

First International Location Opens in Miami

Octane.Rent opened its first international location in Brickell, Miami, in 2026. The opening takes a company founded in Dubai into Miami, a major luxury travel and lifestyle destination in the United States. The Miami team serves visitors and residents across Miami and Florida and rents luxury, sports, and electric vehicles.

Miami shares several features with Dubai: international visitors, a strong resident luxury market, and a year-round season for open-top driving.

Next Steps for the Fleet

Octane.Rent plans to keep investing in its fleet and in its digital booking and support services, the same areas it named after its 2025 award. The company thanks its customers, partners, and team members for the votes and the trust behind the 2026 awards.

About Octane.Rent

Octane.Rent (Octane Club Premium Car Rental L.L.C.) is a luxury and sports car rental company headquartered in Al Quoz Industrial Area 3, Dubai, with locations in Abu Dhabi, Sharjah, and Miami. The company rents luxury, sports, and electric vehicles by the day, week, or month and holds a 4.9 out of 5 rating from more than 1,700 reviews on Google. For more information, visit octane.rent.

Media Contact

Daria Makeeva
info@octane.rent
+971 56 444 0055

November 19, 2026 10:26 AM
EDT
•
TIANJIN, China

NESTA Launches Global Website, Providing Access to New Energy Vehicle Electric Safety Information

TIANJIN, China, November 19, 2026 (EZ Newswire) -- NESTA (New Energy Vehicle Electric Safety Technical Assessment), the world's first technical assessment system dedicated to the electric safety of new energy vehicles (NEVs), officially launched its global website on Nov. 13, 2026. The website provides consumers, automakers, and industry professionals worldwide with access to NEV electric safety information. Supported by the testing and verification capabilities of CATARC New Energy Vehicle Inspection (Tianjin) Co., Ltd., NESTA provides transparent, searchable information on NEV electric safety performance through independent third-party technical assessment.

As NEVs become increasingly widespread across global markets, differences in climate, charging environments, and road conditions create diverse electric safety requirements. NESTA has established a comprehensive technical assessment framework covering six dimensions: charging safety, electromagnetic safety, functional safety, high-voltage safety, battery safety, and fire safety. The system aims to continually reduce electric safety risks, improve user satisfaction, and promote collective industry efforts toward its long-term vision of “zero spontaneous vehicle combustion, zero loss of vehicle control, zero casualties, and zero vehicle-use anxiety.”

Since its launch in November 2023, NESTA has completed more than 700 verification and assessment projects covering 197 categories of test conditions, identified and resolved over 200 electric safety issues, and provided end-to-end technical support for more than 70 vehicle models. NESTA Global was officially introduced in November 2025. To address representative extreme operating environments — including the hot, arid climate of the Middle East; the hot, humid conditions of Southeast Asia; extreme cold in Northern Europe and Russia; and typical demanding conditions in China — it developed 11 specialized verification projects, forming a region-specific testing matrix.

On Nov. 13, 2026, CATARC New Energy Vehicle Inspection (Tianjin) Co., Ltd. officially released NESTA 2027. Guided by the principles of supporting innovative product design and development, covering the entire product lifecycle, and addressing real-world applications across global markets, the updated system strengthens multiple verification projects and establishes a framework comprising 11 core items and 29 extended items, for a total of 40 verification projects.

For NEV users worldwide, the NESTA global website provides neutral and credible third-party information on vehicle electric safety. It presents the vehicle models assessed under NESTA, together with the dimensions covered by each assessment, and allows users to search verification results online. Consumers can use the website to obtain information on the electric safety performance of NEVs sold in their respective countries, offering a new way to better understand NEV electric safety quality.

For automotive industry stakeholders, the website also showcases CATARC New Energy Vehicle Inspection (Tianjin) Co., Ltd.’s approach to scenario-based electric safety assessment, as well as its capabilities and experience in testing vehicles against operating conditions in global markets. This can help automakers identify electric safety risks in products developed for international markets, implement and verify technical improvements, and enhance development efficiency and product quality.

Looking ahead, as the NEV industry moves toward greater product diversity, intelligent technologies, and digitalization, NESTA will continue to enhance its technical assessment system and testing capabilities. It will also strengthen technical exchanges and cooperation with international automotive industry partners to advance NEV electric safety worldwide.

About CATARC New Energy Vehicle Inspection (Tianjin) Co., Ltd.

CATARC New Energy Vehicle Inspection (Tianjin) Co., Ltd. is a wholly owned subsidiary of China Automotive Technology and Research Center Co., Ltd. (CATARC), with a total investment of RMB 2.426 billion. It has comprehensive testing, evaluation and validation capabilities covering the entire R&D process, the full product range, the complete lifecycle and all application areas of new energy vehicles (NEVs). Covering a total area of approximately 405 mu (27 hectares), the facility comprises more than 20 integrated laboratories dedicated to complete vehicle testing, electromagnetic compatibility (EMC), charging technologies, power batteries, hydrogen energy and fuel cells, electric drive systems and electronic control systems. Its specialized testing facilities include a full-vehicle electromagnetic reverberation chamber, an automotive-grade lightning effects test chamber, an underbody impact test track, a full-vehicle water-wading test pool, integrated charging test facilities, and a fire testing laboratory.

Media Contact

Peng Hu
hupeng@catarc.ac.cn

November 19, 2026 9:24 AM
EDT
•
BERLIN, Germany

Shimrit Nativ Launches The Freedom Intelligence Field, Bringing AI and Human Coaching Together Through the Human Instrument® Mastery Method

BERLIN, Germany, November 19, 2026 (EZ Newswire) -- Master Your Path, the coaching company founded by author and transformational mentor Shimrit Nativ, has announced the public launch of The Freedom Intelligence Field, a new AI + Human coaching platform built on Nativ's proprietary Human Instrument® Mastery Method.

As artificial intelligence becomes increasingly integrated into personal development, The Field introduces an approach that combines immediate access to AI-powered guidance with ongoing human connection. Rather than treating AI as a replacement for coaching, the platform brings both together to make personal transformation work more accessible and continuous in everyday life.

At the center of The Field is an AI coaching environment trained on Nativ's Human Instrument® Mastery Method. Members can engage in personalized conversations and access a growing library of more than 20 structured processes designed to help them navigate emotional patterns, shift limiting beliefs, strengthen self-leadership, and translate personal insights into meaningful action.

For someone navigating a difficult conversation, an emotional trigger, or an important decision, the opportunity to shift their response often arises long before their next coaching session. The Field is designed for precisely those moments, giving members immediate access to structured guidance that helps them recognize their patterns, shift their perspective, and make conscious choices in real time. What was once primarily available through scheduled sessions and structured programs becomes part of everyday life.

The AI experience is complemented by a live human support system that includes a dedicated Success Coach, monthly live calls, and a private member community. The platform also draws on the wider Master Your Path ecosystem, where coaches trained and certified in the methodology bring its principles into their own work with clients internationally.

“AI alone is not coaching, and human support alone cannot provide the continuity people need between sessions,” said Nativ. “What becomes possible when we bring them together is something entirely new. The AI makes the depth of the methodology available in everyday life, whenever someone needs it. The human element brings personal guidance, live teaching, community, and genuine connection. Together, they create an experience that extends far beyond what either could offer alone.”

The Freedom Intelligence Field offers two ways to begin. The 72-Hour Power Reset provides a focused three-day guided experience, while The Field Unlimited offers ongoing access to the full library of structured processes, personalized AI conversations in Nativ's voice, monthly live coaching calls, a dedicated Success Coach, and the global member community.

Nativ is the founder of Master Your Path, creator of the Human Instrument® Mastery Method, and best-selling author of "The Skill of Freedom: Crack the Code of the Human Instrument®," featuring a foreword by Neale Donald Walsch. Drawing on neuroscience, subconscious reprogramming, and the principles of conscious creation, her methodology provides a practical framework for personal transformation and self-leadership. Through the Master Your Path Coaching Academy, she has trained and certified coaches internationally to bring the methodology to their own clients. Nativ is also an International Coaching Federation (ICF)-trained professional coach who has studied personally with influential teachers including Dr. Joe Dispenza, Bob Proctor, Neale Donald Walsch, and others.

“Every tool I have ever built has had the same question at its center: what would it take for this person to fully recognize and express the truth of their potential and who they are?” said Nativ. “The Field is the next evolution of that work. It brings the depth of the methodology into everyday life, making guidance and support available in real time, while keeping human connection at the heart of the experience.”

The Freedom Intelligence Field is now available at hello.thefieldai.app. Those ready to experience the work can begin with the 72-Hour Power Reset or step directly into The Field Unlimited for the complete AI + Human coaching experience.

About Master Your Path

Master Your Path is a personal development and coaching company founded by Shimrit Nativ, creator of the Human Instrument® Mastery Method. The company offers mentorship, group programs, professional coach certification, couples coaching, and The Freedom Intelligence Field, serving an international community of clients and practitioners. Learn more at shimritnativ.com.

Media Contact

Master Your Path
support@shimritnativ.com

November 19, 2026 8:37 AM
EDT
•
BEIJING, China

Chinese Consulate General in New York Hosts Event Commemorating the 80th Anniversary of the Opening of the Tokyo Trial

BEIJING, China, November 19, 2026 (EZ Newswire) -- On Nov. 13, the Consulate General of the People's Republic of China in New York hosted an event themed "Learning from History, Upholding Justice, Aspiring for Peace" to commemorate the 80th anniversary of the opening of the Tokyo Trial. Acting Consul General Ma Xiaoxiao attended and delivered remarks. Doug Fitch — a descendant of George Fitch, who served as director of the International Committee for the Nanjing Safety Zone — also spoke. Ying-Ying Chang, mother of Chinese American author Iris Chang, and Boston College historian Franziska Seraphim addressed the gathering by video. More than 100 people from various sectors across the consular district took part, with a particularly strong turnout among young people. As part of the commemoration, the Consulate General hosted a photo exhibition organized by the Memorial Hall of the Victims in Nanjing Massacre by Japanese Invaders and the China Intercontinental Communication Center, with support from the Zhejiang Provincial Association for International Cultural Exchange.

In his address, Ma described the Tokyo Trial as the most significant legal reckoning with Japan's crimes of aggression during World War II and a cornerstone of the postwar international order. Japanese militarism, he stressed, must be completely eradicated, and there must be full accountability for past crimes. He also underscored that the rise of neo-militarism must be firmly resisted, warning that truth must never be distorted, aggression glorified, or peace eroded.

Recalling how the American Flying Tigers crossed the ocean to fight alongside Chinese soldiers and civilians, Ma outlined China's recent handover to the United States of the remains of American airmen who had flown the Hump Route in support of China's resistance against Japanese aggression. At the event, he guided guests through the themed photo exhibition commemorating the 80th anniversary of the opening of the Tokyo Trial. The Chinese and U.S. heads of state, Ma said, had reflected in September on their countries' history of fighting side by side during the war. Both sides should draw wisdom and strength from that shared history and contribute greater certainty and positive energy to world peace, development, and prosperity, he added.

The event also featured a special screening of "Dead to Rights", which drew a full house. Deeply moved by the film, many attendees called the atrocities committed in China by invading Japanese forces appalling, noting that the screening deepened their understanding of the Tokyo Trial's profound historical significance and underscored that peace is hard-won and history must never be forgotten.

About China Intercontinental Communication Center

At the China Intercontinental Communication Center, we share China's stories with the world. Founded in December 1993, we bring this vision to life through film and television production and distribution, book and periodical publishing, digital media, and cultural exchange programs. Our work reaches audiences in more than 200 countries and regions, building connections across cultures.

Media Contact

fanqianhua@cicc.org.cn

November 18, 2026 9:08 PM
EDT
•
WASHINGTON, DC

American Kratom Association Calls on Sen. Grassley to Produce Forensic Evidence Behind Deaths He Attributes to Kratom

WASHINGTON, DC, November 18, 2026 (EZ Newswire) -- The American Kratom Association (AKA) challenged the claims made by Sen. Chuck Grassley, R-Iowa, at his event today with families who have lost loved ones, disputing the reliability of the death classifications at its center. AKA said a finding of “mitragynine toxicity” reached through mitragynine-only testing cannot be accepted as proof that natural botanical kratom killed anyone, and called on the senator to produce the full forensic record before using those deaths to justify federal policy.

“Every family that has lost a loved one deserves compassion, respect, and, above all, the truth about what caused a death that has been reported as a kratom death,” said Mac Haddow, senior fellow on public policy for the American Kratom Association.

Each of These Deaths Is a Complicated Situation, and Complicated Situations Deserve Accurate Answers, Not Politicization and Demagoguery

“In each of the cases of the mothers who participated with Sen. Grassley in his event, we know there are significant, legitimate questions that have now been raised about the role, if any, that kratom played in the death,” Haddow said.

“In the Strang case, we now know, based on the federal prosecutor’s records, that the product cited as purchased by the student was a federally controlled MGM-15 product that is not kratom,” Haddow said. “In the Rustici case, we now know that the daughter had failed to comply with the prescription medications for a serious underlying health condition that was ignored by the medical examiner because it was convenient to call it a kratom death. There is no legitimate justification for that conclusion. In the Eppard case, we know that the autopsy identified a very serious underlying health condition that had caused multiple seizures with this individual that was ignored by the medical examiner.”

Federal court filings in the Mississippi case report that toxicology found MGM-15 and MGPI, both Schedule I controlled substances, in the student’s blood alongside mitragynine, and that the product recovered was labeled as containing MGM-15.

NMS Labs, one of the nation’s leading forensic toxicology laboratories, has now put the underlying problem in writing. Its advisory, “Mitragynine Alone No Longer Tells the Story: Rethinking Kratom Testing,” warns that laboratories working with older or limited methods can overlook the compounds actually driving toxicity or get the exposure wrong entirely. It reports that many commercial products contain far more 7-OH than natural leaf, that mitragynine pseudoindoxyl and MGM-15 have turned up in toxicology casework, and that deaths involving kratom are often complicated by other drugs. AKA said that warning applies with full force to deaths already on the books: cases previously recorded as kratom-involved must now be re-evaluated through a more detailed analysis of what actually caused each death.

“The title of that advisory says it all: ‘Mitragynine Alone No Longer Tells the Story,’” Haddow said. “NMS Labs says a mitragynine-positive result by itself may no longer adequately describe what a person was actually exposed to, and that sorting out the role of any one substance takes a careful evaluation of the complete toxicology. If mitragynine alone does not tell the story in the laboratory, it does not tell the story on a death certificate either. A classification built on that single finding should not be presented to the public, or to the United States Senate, as settled fact.”

AKA’s compassion for these families is unqualified. Its confidence in the conclusions they were handed is not. For each death cited, AKA is asking Sen. Grassley to answer four questions. Was 7-hydroxymitragynine (7-OH) identified and quantified? Was the sample tested for mitragynine pseudoindoxyl (MGPI), MGM-15, and MGM-16? Was the product the person actually consumed recovered and analyzed? Were other substances and underlying medical conditions fully evaluated? Until those questions are answered, AKA said, the assertion that mitragynine caused these deaths is an unproven claim, not an established fact.

A Mitragynine Finding Is Not Proof of a Kratom Death

The claim that these deaths were caused by natural kratom does not withstand scrutiny. A peer-reviewed 2016 study led by Alicia Lydecker in the Journal of Medical Toxicology documented commercial products marketed as kratom that contained 7-hydroxymitragynine (7-OH) at levels far above the trace amounts found in natural kratom leaf, in some cases more than 500% above natural-leaf reference levels. The researchers concluded the findings strongly suggested adulteration. Adulterated products were being sold as kratom at least a decade ago, years before chemically manipulated 7-OH was widely recognized as a public health threat.

AKA’s position follows directly: detecting mitragynine alone is not sufficient to establish that natural botanical kratom caused or contributed to a death. That determination requires a complete evaluation of the toxicology, the medical history, the circumstances of death, and, whenever possible, the actual product consumed. Any death classification that skipped those steps is open to challenge, and AKA is challenging it.

“As scientific knowledge advances and new forensic testing methods become available, it is essential that previous conclusions attributing deaths to kratom be evaluated in light of that new evidence,” Haddow said. “Recent research has identified significant limitations in older toxicology methods, particularly their ability to distinguish natural botanical kratom from products containing elevated concentrations of 7-OH and other potent opioid compounds.”

“The pursuit of truth requires that medical examiners, coroners, and public health officials remain willing to reconsider past conclusions when new scientific evidence raises legitimate questions about their accuracy,” Haddow continued. “This is not about dismissing past findings or minimizing the tragedy of any death. It is about ensuring that families receive the most accurate answers science can provide and that public health policies are based on reliable, up-to-date evidence.”

AKA is calling on medical examiners, coroners, forensic laboratories, and public health agencies to apply modern quantitative testing standards and to reassess historical kratom-associated fatalities where the original testing did not distinguish these compounds and retained evidence permits meaningful review. Some medical examiners plainly got it wrong, and in doing so compounded a family’s grief with an inaccurate account of how a loved one died. Others reached conclusions without information now recognized as essential. Neither kind of finding is a sound basis for federal law.

The Real Danger, and the Policy That Addresses It

AKA recognizes the serious risks posed by chemically manipulated products containing 7-OH, MGPI, MGM-15, and MGM-16, including respiratory depression, dependence, overdose, and potentially death. The Drug Enforcement Administration temporarily placed MGPI, MGM-15, and MGM-16 in Schedule I on Aug. 26, 2026. AKA strongly supports Connor’s End Gas Station Heroin Act (S. 5383 and H.R. 10272), which would remove these products from the marketplace, and the Kratom Consumer Protection Act, which sets age restrictions, labeling, and testing standards for natural kratom.

When death classifications fail to separate natural kratom from these products, lawmakers end up banning the botanical on the strength of unverified findings while the products responsible for the greatest harm go untargeted.

“Sen. Grassley and his colleagues need to base public policy on that truth, not the grief of a family that might be misplaced because of inadequate testing or inaccurate conclusions of a medical examiner,” Haddow said.

An Invitation to Reporters: Cover the Other Families in This Story

AKA encourages journalists covering today’s news from Sen. Grassley to also report on the Americans who use natural kratom safely and responsibly, including veterans, people living with chronic pain, and people who credit kratom with helping them leave far more dangerous substances behind. Their stories belong in any complete account of this issue, and they are available on the record:

To view interviews with participants from the American Kratom Association's October 2026 congressional briefing, visit the AKA Congressional Briefing YouTube playlist.

Watch Christian's personal story to hear in his own words how kratom saved his life.

AKA will arrange interviews with kratom consumers, scientists, and policy experts on request.

Scientific References

About American Kratom Association

The American Kratom Association is a consumer advocacy organization committed to protecting access to safe, natural kratom leaf products and advancing science-based consumer protection standards. AKA supports age restrictions, accurate labeling, contaminant testing, good manufacturing practices, and strong enforcement against adulterated, mislabeled, synthetic, semi-synthetic, concentrated, fortified, or chemically manipulated products falsely marketed as kratom.

Important Disclosures

The American Kratom Association (AKA) is a 501(c)(4) nonprofit advocacy organization. This press release is issued for informational and public policy purposes only. The information contained herein reflects policy analysis regarding federal administrative actions and does not constitute legal, regulatory, or medical advice. Statements regarding natural kratom leaf products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Readers should consult qualified health care professionals regarding personal medical decisions.

Media Contact

Mac Haddow
Senior Fellow on Public Policy, American Kratom Association
press@americankratom.org
+1 571-294-5978

November 18, 2026 5:50 PM
EDT
•
WHITE PLAINS, NY

How Lever & Ecker, PLLC Shows Up for Its Neighbors

WHITE PLAINS, NY, November 18, 2026 (EZ Newswire) -- David B. Lever wanted to do more than open an office and hang a shingle when he founded Lever & Ecker, PLLC. He wanted to show up for the people, families and organizations in his community in a tangible way.

His inspiration for community outreach started at home. His brother, Jeffrey, was born with intellectual and developmental disabilities, and David grew up watching his parents, Carol and Harold, dedicate themselves to creating opportunities for Jeffrey and others like him.

That connection to Adults & Children with Learning & Developmental Disabilities, better known as ACLD, goes back more than 50 years. It began with an after-school program in Westbury, and before long the whole Lever family was involved. ACLD offers programs and services that help children and adults with autism, learning disabilities and other developmental disabilities gain independence, build relationships and live meaningful lives.

Harold joined the Board of Trustees in the early 1980s, and Carol also joined the Board of Trustees and became a founding member of its Planned Giving Society. In 2020, David followed in their footsteps and joined the Board of Directors.

"Serving in this capacity honors my family's legacy of supporting an organization that has allowed my brother and many others to learn, thrive and live a life filled with meaning and dignity," Lever said.

At Lever & Ecker, PLLC, community service looks different for each partner. Each has chosen to get involved with a cause that means something personal to them.

Founding partner Daniel G. Ecker supports The Sharing Shelf, a Westchester nonprofit working to end clothing insecurity among children and teenagers. It's a need that's easy to miss in a county often associated with affluence. But plenty of local families are stretching to cover housing, food and other necessities, and keeping fast-growing kids in clothes that fit and suit the season can be a tremendous relief.

The Sharing Shelf provides much more than clothing, including diapers, hygiene and period products, backpacks and school supplies. It works through schools and social-service agencies, and in 2025 alone it provided clothing to 8,540 children, distributed 1,976 backpacks and worked with 185 community partners.

For Ecker, it's a chance to help with a need that is fundamental and often invisible.

"A child who does not have a winter coat, shoes that fit or enough clean clothing for school may face challenges that extend well beyond physical comfort. Having basic necessities can affect confidence, participation in school and a child's sense of belonging," Ecker said.

Partner Adam C. Weiss has focused much of his community work on CLUSTER Community Services, a Yonkers-based nonprofit that has served residents across Westchester and Rockland Counties for decades. Most recently, CLUSTER has expanded its reach and is now also serving the Bronx. 

CLUSTER reaches people at very different moments in their lives. Its mental-health programs offer transitional and permanent supportive housing for individuals with mental illness and addictive disorder. Its Housing Resource Center helps residents at risk of homelessness with eviction prevention. Its youth programs provide summer camp as well as academic and enrichment opportunities, and its mediation centers help the Courts, individuals, families, and businesses resolve disputes.

Adam joined the Board of Directors and was selected as board chair in 2023. In announcing his appointment, CLUSTER noted that he had already helped lead several initiatives, including its Giving Tuesday efforts.

"The work that CLUSTER has done throughout Westchester and Rockland, and now the Bronx, providing services supporting mental health, eviction prevention, dispute resolution, and enriching the lives of our youth is incredibly impressive and motivational," Weiss said.

David, Dan and Adam support very different organizations for very different reasons. What they share is a belief that being part of a community carries responsibilities that don't end when the workday does.

Community involvement can certainly build relationships and strengthen trust for a local business. But the most meaningful kind usually starts somewhere else: with a cause that matters personally and a willingness to pitch in.

That's what turns community involvement from a business strategy into something much simpler.

Being a good neighbor.

About Lever & Ecker, PLLC

Lever & Ecker, PLLC is a New York-based plaintiff’s personal injury law firm dedicated to representing individuals and families affected by serious injury and wrongful death. The firm is known for its client-centered approach and track record of achieving significant results in complex cases. For more information, visit leverecker.com.

Attorney Advertising Disclaimer

This press release may constitute attorney advertising in certain jurisdictions. Prior results do not guarantee a similar outcome.

Media Contact

Amanda Orr
Orr Strategy Group
amanda@orrstrategygroup.com

November 18, 2026 11:54 AM
EDT
•
ISTANBUL, Türkiye

Esnan Dental Clinics Approaches 20th Anniversary With Landmark International Achievements

ISTANBUL, Türkiye, November 18, 2026 (EZ Newswire) -- Esnan Dental Clinics is approaching its 20th anniversary with a series of international achievements, quality accreditations, and technological milestones. Established in 2007, Esnan Dental Clinics now operates five clinics with a team of more than 80 dentists, serving both domestic and international patients.

Throughout its two-decade journey, clinical expertise, teamwork, advanced technology, and a commitment to patient trust have remained central to its development.

From Istanbul to the World: A 20-Year Journey

A significant milestone in the growth of Esnan Dental Clinics was the opening of Esnan Skyland Clinic in 2023. Spanning 4,500 square meters and featuring 38 dental units, the facility ranks among Europe's larger private dental clinics, bringing multiple dental specialties, advanced technologies, and surgical capabilities together under one roof.

Alongside its five clinics in Istanbul, Esnan Dental Clinics supports international patient communication and treatment coordination through its offices in London and New York, serving patients traveling from different parts of the world.

International Accreditations Recognizing Quality and Patient Safety

A defining aspect of the international development of Esnan Dental Clinics is its commitment to independent assessments of clinical quality and patient safety.

In July 2026, Esnan Dental Clinics became the first dental clinic in Türkiye to receive Joint Commission International (JCI) accreditation, under the Ambulatory Care Program. The accreditation assesses internationally recognized standards covering patient safety, clinical processes, infection prevention, and health care quality.

Esnan Skyland Clinic also holds Temos International accreditations in Quality in Dental Care and Excellence in Dental Tourism. In December 2025, the clinic achieved the highest possible assessment score for Excellence in Dental Tourism.

Esnan Dental Clinics is the only dental clinic in Türkiye to hold both prestigious international health care accreditations, JCI and Temos, simultaneously.

Together, these recognitions reflect the commitment of Esnan Dental Clinics to internationally recognized standards across clinical care, patient safety, and the international patient journey.

Global Technology Partnerships and Digital Dentistry

In March 2026, Esnan Dental Clinics and its in-house laboratory, Esnan Digital Lab, reached a significant milestone through a strategic partnership with Amann Girrbach, becoming the world's first Founding Diamond Partner Clinic and Laboratory.

Esnan Digital Lab works closely with clinical teams to support an integrated digital workflow, from treatment planning and digital design to the production of dental restorations. This infrastructure helps maintain consistent technological and production standards across the clinics.

Esnan Dental Clinics has also received recognition from leading global implant manufacturers. In 2025, the organization was awarded by Straumann and Medentika for achieving the highest implant usage volume in Türkiye.

These achievements highlight the long-term commitment of Esnan Dental Clinics to clinical innovation, advanced dental technologies, and partnerships with internationally recognized manufacturers.

"Our Greatest Achievement Is the Team Behind Our Success"

Clinical expertise and collaboration have played a defining role in the development of Esnan Dental Clinics. Its CEO, Dr. Serdar Yenigün, is an experienced dental surgeon who has practiced extensively within Esnan Dental Clinics and performed more than 42,000 dental implant procedures throughout his career. His clinical background continues to inform the organization's approach to quality, innovation, and patient-centered care.

Commenting on the upcoming anniversary, Dr. Yenigün said:

"What Esnan Dental Clinics has achieved today is the result of the collective dedication of our dentists, surgical teams, laboratory specialists, and every member of our organization. Throughout our 20-year journey, we have remained focused on combining clinical expertise with technology and innovation while maintaining high standards of care.

"For us, success is measured not only by the treatments we provide, but by the trust our patients place in us. Dental treatment is an important decision that can influence a person's health and quality of life for many years. That is why we believe every patient deserves the same commitment to quality and institutional reassurance, regardless of which of our clinics or clinicians they visit.

"Our international accreditations, investment in Esnan Skyland Clinic, and partnerships with global technology leaders are tangible reflections of this commitment.

"As we approach our 20th anniversary, our greatest source of pride is the team that has made these achievements possible. We will continue investing in clinical excellence, advancing our technological capabilities, and improving the patient experience at every stage of care."

Building on 20 Years of Experience

As Esnan Dental Clinics approaches its 20th anniversary, enhancing the patient experience remains a key priority.

From the first consultation and personalized treatment planning to clinical care and post-treatment follow-up, Esnan Dental Clinics emphasizes transparency, continuity, and long-term patient relationships.

The organization is also exploring opportunities to collaborate with independent health care providers in different countries to further support international patients after they return home.

For Esnan Dental Clinics, 2027 represents more than the celebration of two decades of achievement. It marks an opportunity to recognize the people, clinical expertise, and patient trust behind its success while continuing to build on these foundations for the future.

About Esnan Dental Clinics

Founded in 2007, Esnan Dental Clinics is a dental health care group with five clinics in Istanbul, Türkiye. Esnan Skyland Clinic provides care for international patients, supported by a dedicated international patient coordination team. Esnan holds Joint Commission International (JCI) accreditation under the Ambulatory Care Program, while Esnan Skyland Clinic holds Temos accreditations in Quality in Dental Care and Excellence in Dental Tourism. For more information, visit esnandentalclinics.com.

Medical and Dental Tourism Disclaimer

The information in this release is provided for general informational and corporate announcement purposes only and does not constitute medical or dental advice. Surgical and restorative dental procedures, including dental implants, carry inherent clinical considerations and are not suitable for every patient. Candidacy, treatment timelines, healing periods, and clinical outcomes vary based on an individual patient's oral health, medical history, and diagnostic evaluation by a licensed dental professional. International patients considering cross-border dental care should consult with qualified clinicians regarding travel fitness, recovery protocols, and post-treatment follow-up care. International accreditations and manufacturer awards cited in this release reflect institutional assessments and clinical volume recognitions at the time granted and do not guarantee individual treatment results.

Media Contact

abdurrahman.sariaslan@esnan.com.tr

November 18, 2026 11:46 AM
EDT
•
BARCELONA, Spain

Codeway's Retake Reaches 38 Million Users by Replacing Manual Photo Editing With Personal AI Model

BARCELONA, Spain, November 18, 2026 (EZ Newswire) -- Retake, the AI face and selfie editor developed by Codeway, has passed 38 million users worldwide, according to company data. The company reports that the app has grown 48% over the past 12 months and now produces more than 2 million edited photos a month.

Retake builds a separate AI model for each user, trained on 10 of that user's own photos. According to Codeway, training on a person's own images is what allows the output to preserve their identity: the person in the result remains recognizably the person in the original. Once the model is ready, any new photo comes back as a set of finished alternatives refined from the original. Users can also adjust hair and expression, and then pick the version they want to share.

"General image models are built to know everything, and that is their weakness when it comes to faces," said Mehmet Sat, applied AI engineering lead at Codeway. "Retake's model does one thing: faces. Then it goes further and learns yours. A small model focused on one face will beat a huge model that knows a little about everyone."

A model Codeway trains in-house

Retake runs on an image model that Codeway develops and trains in-house, built specifically to be personalized for each user. According to the company, owning the model end to end is what makes a personal model per user practical at this scale. Identity preservation can be set as a training priority, model updates ship on Codeway's own timeline, and the cost of each generated image stays predictable as usage grows.

Users can give any result a thumbs up or down. Styles that receive a thumbs down stop appearing. The app does not include face swapping.

Upcoming

Codeway said a set of new tuning features is in development for Retake and will give users finer control over their results without changing how natural they look. As 2026 draws to a close, the team is building toward a 2027 in which Retake becomes an all-in-one photo app, where the same personal AI profile that fixes a photo can also refine it. The company has not shared feature details or release dates.

Retake is available on the App Store and Google Play in English, French, German, Italian, Japanese, Portuguese, Spanish, and Turkish.

About Retake

Retake is an AI face and selfie editor that generates versions of a user's own photos. Instead of applying filters, it builds a personal model from each user's pictures and generates finished options to choose from. Retake is developed by Codeway and is available on iOS and Android. For more information, visit retake.photos.

About Codeway

Codeway is a mobile technology company based in Barcelona. Its apps, including Retake, Learna, and Cleanup, have been downloaded more than 600 million times. Codeway builds and trains its own AI models. For more information, visit codeway.co.

AI and Privacy Disclaimer

Retake uses proprietary generative artificial intelligence to create personalized photo edits based on user-submitted reference images. Uploaded photos and personal AI models are processed in accordance with Retake's Privacy Policy; facial data is not sold or shared with third parties, is used for broader model training only with explicit user opt-in consent, and may be deleted by the user at any time. Users must own or have explicit permission to use any photographs uploaded to the app and must meet applicable minimum age requirements (16 years or older). Generated images are AI reconstructions intended for personal use and may vary depending on source photo quality and lighting. Statements regarding planned product capabilities and the 2027 product roadmap reflect current development goals and are subject to change without notice.

Media Contact

İpek Şevval Esen
Sr. Partnerships & Social Growth Manager
ipek.esen@codeway.co

November 18, 2026 11:21 AM
EDT
•
LOS ANGELES, CA

Eureka Ergonomic Expands Best-Selling Mathias Collection With Three New Chairs Following 10,000+ Units Sold

LOS ANGELES, CA, November 18, 2026 (EZ Newswire) -- Eureka Ergonomic has announced the expansion of its Mathias Collection with three new seating models — the Marcel High-Back Office Chair, Mason Low-Back Office Chair, and Matteo Napa Leather Lounge Chair with Ottoman — transforming its signature executive chair into a four-model furniture collection designed for work, meetings, and relaxation. The expansion follows sales of more than 10,000 chairs across the Mathias family and marks a significant step in the company's effort to bring coordinated, premium seating solutions to home offices, professional workplaces, and living spaces.

Originally centered on the Mathias Executive Chair, the collection now offers distinct seating options for different activities while maintaining a consistent design identity. From high-back executive seating and low-back guest chairs to a reclining lounge chair, the expanded lineup allows customers to furnish multiple areas of a room with complementary materials, finishes, and silhouettes.

Four chairs, one wood-and-upholstery system

Every chair in the family uses FSC®-certified wood. Eleven layers of wood veneer are laminated and formed into bentwood panels, then finished with a wood veneer that brings the grain and warm tone of the material into the room. Panels are matched to the upholstery rather than fixed per model, so deeper wood tones sit under black and brown leather while lighter tones sit under off-white and fabric.

What separates the four models is how much of that panel the design exposes, how far it curves, and what surrounds it. The Mathias and Marcel use a broad back panel framed by high upholstery. The Mason carries the same panel into a shorter, narrower silhouette with no headrest. The Matteo takes the curve into a wraparound lounge profile, where wood and leather meet along a continuous line. Seen side by side, the family reads as one design decision applied at four scales — which is why chairs from different price points can share a room without competing.

Watch "Mathias Executive Office Chair: The Art of Craftsmanship" on YouTube.

Mathias: The model the family is built around

Mathias is the reference point. It pairs a classic executive silhouette with Napa leather across the primary touch surfaces, a curved wood back panel, thick padding over the seat and back, a tilt mechanism, an aluminum alloy five-star base, and a Class 4 gas cylinder, and it is built to contract grade.

Where Mathias separates itself is fit. Three versions cover different statures rather than different styles.

  • Standard is rated for users from 5'3" to 6', with a 19.29"–21.06" seat height, a 17.32" seat width and a 330 lb capacity.
  • XL widens the seat to 18.5" and raises the height range to 19.69"–22.81" for users from 6' to 6'6", with a 400 lb capacity.
  • Pro keeps the 18.5" seat width and 330 lb capacity but opens the recline to 97°–123°, against 101°–113° on the other two, for a deeper lean-back during reading or a call.

Upholstery follows the same logic. Beyond black, beige, and brown Napa leather, Mathias is offered in Slate Green and Off-White fabric for buyers furnishing a home study rather than a corporate office. The chair is the one most buyers will keep through a job change, a move, or a renovation, which is the argument for choosing it first and building the rest of the room around it.

Marcel: High-back support for everyday office use

Marcel is the full high-back option for buyers who want the executive profile without the maintenance schedule of genuine leather. The silhouette is complete — high back, fixed integrated headrest, curved wood back panel, upholstery carried through the arms — and the upholstery is a quality faux leather chosen for daily handling: soft to the touch, easy to wipe down, and free of the conditioning routine that Napa leather asks for.

The adjustments are aimed at a working day rather than a showroom. Seat height adjustment and 360° swivel handle desk work and movement around a workstation. The back reclines from 95° to 115° and can be locked upright at 95°, so the chair holds a focused posture for desk work and releases into a lean-back between tasks.

Mason: Low-back, open sightlines for meetings and reception

Mason takes the family into the seats around the desk rather than behind it. The back is low and there is no headrest, so the chair reaches roughly shoulder height and leaves the sightline across a room intact — a practical difference in open offices, small meeting rooms, and reception areas where a row of high backs would block the space.

Its armrests also mark it out. Where other chairs in the family use wood-panel armrests, Mason uses an electroplated metal frame with upholstered support, so metal, faux leather, and wood meet on one chair. The seat is wide and thickly padded, and the recline matches Marcel at 95°–115° with the same 95° upright lock. Placed beside a Mathias or a Marcel, the height difference creates a natural hierarchy between the primary seat and the guest seats while the shared wood detailing keeps the arrangement consistent.

Matteo: A lounge recliner for the hours after work

Matteo is the family's departure in purpose, not in language. It is a lounge chair and ottoman built on the same bentwood construction, with Napa leather across the body-contact areas and a wraparound back, a generously padded seat, and supportive armrests shaping a deeper, more open seating position than an office chair allows.

The range of motion is what sets it apart. The backrest adjusts through four positions between 130° and 160°, the headrest moves in both position and height to follow the angle of the lean, and the matching ottoman extends support from the back through to the legs. The chair swivels on an aluminum alloy base, carries a 660 lb capacity, and is recommended for users from 5'5" to 6'5". None of this replaces a desk chair; it gives the reading corner, the living room, or the end of a home office a seat built for staying in rather than sitting up.

High-back, low-back, lounge: How the four models differ

The four models separate cleanly on five points, and buyers can usually settle the choice with the first two:

Fit

Mathias is the only model offered in three sizes, with Standard, XL, and Pro covering users from 5'3" to 6'6" and capacities from 330 lb to 400 lb. Marcel and Mason are single-size chairs; Mason's lower, narrower profile suits smaller builds and tighter floor plans, and both are worth checking against stated dimensions before ordering. Matteo is recommended for 5'5" to 6'5".

Upholstery and upkeep

Mathias and Matteo use Napa leather on primary touch surfaces, which rewards occasional conditioning and develops a patina over time. Marcel and Mason use faux leather, which wipes clean and needs no conditioning — the reason both are often specified for shared and client-facing rooms where several people use the same chair.

Recline range

Marcel and Mason run 95°–115° with a 95° upright lock, sized for working postures. Mathias Standard and XL run 101°–113°, and Mathias Pro extends to 97°–123°. Matteo runs 130°–160° across four positions, which is a lounging range rather than a working one.

Sightlines and room type

High backs suit private offices, closed studies, and any seat where the chair is part of the room's composition. Low backs suit open offices, meeting rooms, reception, and consultation areas, where seeing across the space matters more than the chair's own profile.

Mixing

Because panel curvature, veneer tone, and upholstery pairing are shared, chairs from different models can be combined in one room without matching. A high-back at the desk and low-backs at the guest seats is the most common arrangement; adding a Matteo in a corner completes the room without introducing a second design vocabulary.

A family, not four separate chairs

The value of the expansion is not the number of models. It is that a buyer furnishing one room — or one floor — can now choose seating by how each seat is used: the chair behind the desk, the chairs for visitors, the chair for the end of the day. The wood panel, the veneer tone, and the upholstery pairing hold those choices together, so a room assembled from four different models still reads as a single decision.

That is also where the collection sits within Eureka Ergonomic's approach to attainable luxury: design that carries a signature, materials that can be seen and felt, and adjustments that are used rather than listed. The Mathias family takes that approach across the whole room instead of a single chair.

Specifications and finish options for the Mathias seating collection for office and lounge are listed on the Eureka Ergonomic site. The wood-forming process behind the collection is described in the design notes on its curved-wood construction.

About Eureka Ergonomic

At Eureka Ergonomic, we believe furniture should fit the way people live. Great furniture is about more than how it looks. It's about how it feels, how it functions, and how naturally it becomes part of everyday life. That's what guides our approach to design. From the home office to the living room, dining room, and bedroom, we create furniture that brings together comfort, functionality, and distinctive design. Whether it's a desk that adapts to your workday or a sofa that brings people together, every piece is made with real life in mind. With our in-house design, engineering, and manufacturing capabilities, we bring ideas to life with close attention to materials, craftsmanship, and detail. We also extend our expertise beyond the home through Eureka Business, furnishing workplaces, hospitality environments, and commercial spaces. Our name, Eureka, means "I found it." For us, it's that moment when a piece feels just right, a space comes together, and everyday life feels a little better. That's what it means to MAKE LIFE BETTER.

Media Contact

Ryan Hu
ryanhu@eurekaergonomic.com

November 18, 2026 9:00 AM
EDT
•
NEW YORK, NY

Smartling Appoints Bharat Mirchandani Chief Product Officer to Accelerate AI Innovation and Global Growth

NEW YORK, NY, November 18, 2026 (EZ Newswire) -- Smartling, the AI translation platform, today announced the appointment of Bharat Mirchandani as its first Chief Product Officer. Mirchandani will lead product management and design as Smartling continues investing in AI innovation, customer experience, and international growth.

Smartling also promoted Max Sogin to Chief Technology Officer and named Andrew Saxe Vice President of Product, Enterprise. Saxe will focus on customer outcomes, bringing strategic account needs directly into product development and delivery.

These appointments follow Vitruvian Partners’ September 2026 majority growth investment in Smartling, which supports continued development of its AI translation platform, agentic localization capabilities, and international expansion.

“The translation industry is being rebuilt around AI, and the companies that win will be the ones that make going global as simple as publishing at home,” said Bryan Murphy, CEO of Smartling. “That’s the bet we’ve made with Vitruvian’s backing. It’s why I wanted a product leader who has scaled products at Amazon, Uber, and Affirm alongside a CTO who knows how to build a platform that helps customers grow. Bharat and Max are the team to turn that bet into reality for our customers.”

Mirchandani brings nearly 20 years of experience building and scaling products at Amazon, Uber, Affirm, and Spring Health. Most recently, he served as Vice President of Product Management and Growth Marketing at Spring Health, leading product and growth initiatives that included AI-powered solutions.

“I’m excited to join the Smartling team and build on its deep translation expertise,” said Mirchandani. “Whether companies are entering new markets, running marketing campaigns, or supporting customers, language should help them grow. By combining AI translation with agentic capabilities that simplify and automate the work around it, we can help enterprises reach more customers, move faster, and reduce costs while maintaining the quality they depend on.”

Advancing AI translation across content and workflows

Smartling will launch and showcase new video, image, and AI workflow capabilities and outline its product roadmap at “The State of Translation: AI and the New Rules of Global Growth” in London on Dec. 3. The company will demonstrate how customers can use its latest products to translate more content across formats and manage translation within the tools they already use, while sharing its priorities for continued innovation.

Media Translation Studio will bring automatic video transcription, subtitle translation, and review into Smartling’s existing workflows. Image Translation will enable teams to translate text in website images, screenshots, e-commerce product images, and social graphics without the original design files, reducing the manual work involved in adapting content for different markets.

Smartling is also bringing translation to the places teams already work. A new AI assistant inside the platform will let customers ask questions and take supported account actions in plain language. Enhancements to Smartling’s Model Context Protocol (MCP) server and new connectors will also extend translation across AI tools and enterprise systems.

At the event, Smartling will release its "State of Translation" report, examining a year of platform data on translation demand, AI and human workflows, and turnaround times.

Smartling serves more than 1,000 global brands and was named a Leader in “The Forrester Wave™: Localization Services, Q3 2026.”

About Smartling

Smartling helps global enterprises bring more content to more markets, faster. Its LanguageAI™ platform combines AI translation, workflow automation, and quality assurance with expert language services, so teams can publish with the quality, trust, and oversight enterprise AI translation requires. More than 1,000 global brands rely on Smartling to translate billions of words a year.

Media Contact

Kayla Guglielmo
Smartling
kayla@sixeastern.com

November 17, 2026 7:20 PM
EDT
•
NEW YORK, NY

One Strategy Group Develops Proprietary Recruiting Database Based on Over 4,000 Student Job Offers

NEW YORK, NY, November 17, 2026 (EZ Newswire) -- One Strategy Group (OSG), a career training firm specializing in finance recruiting, from investment banking to private equity, hedge funds, and other buy-side firms, as well as quantitative finance, consulting, and technology, has developed a proprietary recruiting database built on more than 4,000 offers received by its students over the past seven years. The database pairs historical recruiting outcomes with real-time insights from working professionals to build preparation strategies tailored to each student's academic background, target role, and geographic market.

Recent cycles show how quickly it has grown. OSG students received 154 offers in 2021, 408 in 2022, 566 in 2023, 701 in 2024, and 910 in 2025. As of Oct. 12, the 2026 cycle had already produced 697 offers: 164 at bulge-bracket banks, 63 at elite boutiques, 173 at middle-market banks, 87 at private equity and other buy-side firms, 44 at hedge funds and quantitative trading firms, 87 in management and economic consulting, and 79 in technology and other sectors.

Investment banking accounts for the largest share, reflecting how many undergraduates banks hire each year, but the buy-side results are where the numbers become most striking. In the 2025 cycle, OSG students received 10 offers from Blackstone, about a quarter of the firm's roughly 40 U.S. summer analyst positions for 2027, spanning credit and insurance, real estate private equity, real estate capital markets, and tactical opportunities. They also received seven offers from KKR, six from Ares, five from Bain Capital, three from Point72, and one from Bridgewater.

Results in other sectors follow a similar pattern. An OSG student has received Goldman Sachs' New York investment banking sophomore summer offer in each of the past three years, and OSG students received 20 Evercore offers in 2024 and 16 in 2025. In consulting, they secured 123 offers in 2025, 36 of them at McKinsey, BCG, and Bain. Quantitative offers have come from Citadel Securities, Jane Street, Optiver, IMC, and Two Sigma.

What the database captures

The database is built around recruiting outcomes, including students' universities, target roles, employer types, office locations, and application timing. That allows OSG to show a student which firms, groups, and offices candidates with comparable profiles have actually reached, and when they needed to be ready.

This matters most for students outside traditional recruiting pipelines. Guided by that data and his mentors, a Claremont McKenna College economics and computer science student focused on credit investing and received a 2027 summer offer from Ares, along with investment banking offers from Perella Weinberg Partners (PWP), Rothschild & Co, and Bank of America. A New York University drama major repositioned toward asset management and received a 2027 summer analyst offer from Goldman Sachs Asset Management's private equity group.

Mentors who are still in the market

Data shows where to aim. OSG's mentors determine how students get there. Every OSG mentor is a front-line professional active in the industry they coach, whether investment banking, private equity, hedge funds, quantitative trading, consulting, or technology. They include a private equity investment manager at a bulge-bracket bank's asset management arm, a partner at an AI-focused venture capital firm, a technology private equity investor who has led more than $1.5 billion in transactions, and a vice president at a $10 billion alternative asset manager. The quantitative track alone draws on 80 traders and researchers across equity derivatives, commodities, fixed income, and digital assets.

OSG pays premium compensation to recruit and retain mentors of this caliber, so students receive current perspectives on deal activity, market conditions, and hiring priorities rather than secondhand material. Each student works with roughly 40 mentors across more than 70 one-on-one sessions, supplemented by weekly webinars led by managing director-level bankers and consulting partners. Rather than relying on one generalist adviser, candidates receive feedback from specialists in technical preparation, industry knowledge, recruiting strategy, and role-specific mock interviews.

From banking to the buy side

For investment banking candidates, preparation covers financial statement analysis, valuation, transaction concepts, and financial modeling, with mentors testing whether students can defend their assumptions when challenged. Private equity candidates go further into leveraged buyout modeling and investment judgment.

In fundamental investing and long/short equity, candidates must show independent investment reasoning. In one case, OSG arranged for 14 experienced investors to challenge a student's stock pitches ahead of an interview with a major hedge fund, pressing on valuation assumptions, investment risks, and alternative readings of the thesis.

A proprietary quant curriculum

In quantitative finance, OSG first matches each student to trading, research, or development, then trains them through eight learning modules and diagnostic mock interviews scored on accuracy, reasoning speed, and communication. Trading candidates practice on OSG's proprietary simulated exchange; research candidates complete five progressively harder modeling projects. The database adds timing, mapping which firms run early-year programs and where reapplication policies make a first attempt especially consequential.

Keeping pace with AI

As AI reshapes the technology sector, OSG has built out its technology track to match. In the 2026 cycle, its students received 79 offers in technology and other sectors. Recent software engineering offers include OpenAI in San Francisco, Databricks in Silicon Valley, and Amazon, along with AI engineering roles at Bending Spoons, a European technology unicorn, and technology roles at hedge funds Squarepoint and Man Group. With AI automating routine coding, employers now weigh system design, project depth, and communication more heavily, and OSG's technology mentors, all working engineers and product leaders, train students to explain the decisions behind their work, not just the code.

Across every track, OSG emphasizes that effective preparation depends less on access to content than on direction and feedback. The database identifies where opportunities have opened; mentors help students become candidates who can take them.

Although historical recruiting outcomes cannot guarantee future offers, OSG considers its database a resource for helping candidates make informed decisions about career targeting and preparation.

About One Strategy Group (OSG)

Founded in 2018, One Strategy Group (OSG) is a career training firm headquartered in New York, with an additional office in London. It provides specialized preparation for students pursuing careers in investment banking, private equity, hedge funds and other buy-side roles, quantitative finance, management consulting, and technology. OSG serves as an exclusive recruiting partner to more than 100 university student associations. Its services include career assessment, technical training, professional mentorship, recruiting strategy, and interview preparation.

Disclaimer

Past recruiting outcomes and individual student examples reflect historical self-reported offers from program participants and do not guarantee future job offers, interviews, or compensation. Individual results vary based on academic background, prior experience, market conditions, and candidate effort. One Strategy Group (OSG) is an independent career training provider and is not affiliated with, endorsed by, or sponsored by any of the financial institutions, consulting firms, or technology companies mentioned in this release. All mentor perspectives represent personal industry experience and not the official views of their employers.

Media Contact

leon.ye@1strategygroup.com

November 17, 2026 6:44 PM
EDT
•
BROKEN ARROW, OK

Botanic Tonics Responds to CBS’ '60 Minutes': Natural Kratom Leaf and Concentrated Synthetic 7-OH Are Different Products

BROKEN ARROW, OK, November 17, 2026 (EZ Newswire) -- Botanic Tonics today responded to Sunday’s "60 Minutes" segment on kratom, which presented natural kratom leaf and concentrated synthetic 7-OH as a single category and placed accounts involving concentrated synthetic 7-OH alongside feel free CLASSIC. This release sets out the facts the segment left out.

The Segment Treated Two Different Products as One

The evidence was personal accounts

Much of the segment rested on personal accounts and interviewee characterizations rather than data that separates the products. It did not feature a single consumer of natural kratom leaf with a positive experience, although millions of Americans consume it.

Federal agencies separate the products

HHS describes the products it is scheduling as concentrated or enhanced opioid products and separates them from natural botanical kratom. The federal record says so repeatedly:

  • The Justice Department’s October update states that HHS’s analysis confirms 7-OH occurs naturally in botanical kratom at relatively low levels.
  • HHS’s Oct. 9 recommendation is designed to target concentrated or chemically altered products while distinguishing them from natural botanical kratom.
  • The DEA’s temporary scheduling action does not apply to botanical kratom products that contain naturally occurring 7-OH below the specified threshold.
  • In July 2025, HHS said the FDA’s action “is not focused on natural kratom leaf products.”

What feel free CLASSIC is made with

feel free CLASSIC is made with noble kava root and natural kratom leaf. It is not a concentrated synthetic 7-OH product, and natural kratom leaf contains only trace amounts of naturally occurring 7-OH. Botanic Tonics has long supported federal action against concentrated synthetic 7-OH and commended the DEA’s action in August.

Mixed Numbers and Anonymized Data Sets Cannot Speak for Natural Kratom Leaf

The segment applied national figures that never identify which product was involved

The segment cited more than 5,000 kratom-involved overdose deaths since 2020. That figure combines cases from across the country and counts any death in which kratom was present, regardless of product form. It cannot be tied to a specific product or to a particular type of natural kratom leaf, and the segment drew that connection anyway. Linking an aggregate total to feel free CLASSIC is a leap the data cannot support.

CDC overdose data separates kratom detected in post-mortem testing from kratom listed as a cause of death. A CDC analysis of overdose deaths in 27 states found that fentanyl or fentanyl analogs were also listed as a cause of death in 56% of kratom-involved deaths, that toxicology detected multiple substances for almost all decedents, and that kratom was the only substance detected in just seven of 152 deaths in which it was found. A Washington Post review of 2020 through 2022 data likewise found that the vast majority of cases involving kratom also involved other substances. State health departments report that their data cannot identify which specific forms or compounds are involved. The risk federal and state health agencies describe sits with concentrated products: the FDA has linked higher levels of 7-OH in synthetically enhanced products to greater risk of overdose, physical dependence, and withdrawal, and researchers at the University of Washington note that 7-OH is increasingly sold as a stand-alone and more potent product.

A single total cannot tell viewers how many cases involved natural kratom leaf, adulterated products, multiple substances, or concentrated synthetic 7-OH. Post-mortem testing that detects mitragynine cannot show whether it came from natural leaf, an extract, or a concentrate, and the segment did not identify a single death established as caused by natural kratom leaf. Botanic Tonics calls for overdose data to be reported by product type, so the public can see where the risk comes from.

What the Research Shows

A peer-reviewed study of feel free CLASSIC

feel free CLASSIC itself has been studied in people. A peer-reviewed safety study published in Cureus [1] in December 2024 and registered as ISRCTN17198496 tested the product in healthy adults ages 21 to 55. Participants consumed servings over six consecutive days in each of four periods, with a randomized, double-blind, placebo-controlled crossover comparison at the lowest serving and open-label periods at higher servings. Forty participants entered each period.

  • No serious adverse events or deaths were reported.
  • No participant discontinued because of an adverse event.
  • Investigators judged none of the vital sign changes clinically significant.
  • Withdrawal scores on the Clinical Opiate Withdrawal Scale (COWS) stayed below the threshold for mild withdrawal.
  • Each 15 mL serving contained 12.5 mg of mitragynine and less than 0.05 mg of 7-OH.

An FDA-commissioned study of natural kratom leaf

The FDA has also studied natural kratom leaf [2]. The agency commissioned a pilot single ascending dose study with a placebo group, conducted under an Investigational New Drug application. Five cohorts of eight healthy adults each took 1, 3, 8, 10, or 12 grams of encapsulated raw kratom leaf, with two participants per cohort receiving placebo. Preliminary results presented by an FDA pharmacologist in February 2024 reported no serious adverse events.

A growing body of research

These studies are part of a broader body of research. The Global Kratom Coalition [3] catalogs 18 peer-reviewed human studies on kratom, including controlled clinical trials, pharmacokinetic and medication-interaction studies, and observational clinical assessments. Annual kratom publications have grown from roughly 20 in 2016 to more than 130 by 2024. Botanic Tonics’ review of the clinical literature finds that all clinical studies to date used natural kratom leaf and powder, and none exist for extracts, concentrates, or synthetic compounds.

Every Panel of the Bottle Is Built to Inform

Consumer safety sits at the center of everything Botanic Tonics does, from how the company sources its ingredients to how it tests its products, educates consumers, and shares information openly. The feel free CLASSIC label is guided by the science and Botanic Tonics’ own clinical research.

Front of pack

The front of the package states “Can be habit forming” and “Consume responsibly” and carries a statement that the product is for adults 21 and older only.

Sides and back

Clear serving lines run along the sides of the bottle, so the serving size is visible however the bottle is held. The back of the bottle reinforces the serving limit and gives guidance on maximum servings per day. A QR code connects consumers to more information about the product and the research behind it.

Warnings

The label states that the product can be habit-forming and can be harmful if not consumed as directed. It advises against consuming the product with a history of substance abuse or with excessive alcohol, and notes that it can interact with certain medications, so consumers should consult a health care provider.

Third-party label research

Botanic Tonics commissioned a third-party contract research organization to test whether consumers understand the label as intended. In a small pilot study of 1-hour interviews conducted in July 2026, 11 adult consumers, including current kratom consumers and people interested in trying kratom, examined a feel free bottle for the first time.

  • The “Can be habit forming. Consume responsibly” statement on the front was among the most noticed on the bottle, and many participants saw the 21-and-older statement without being prompted.
  • All of the current kratom consumers understood the serving instructions and the importance of consuming as directed, and most participants who had not tried kratom said they would start with less than the directed serving.
  • Participants said the warnings communicated a serious product and that the level of detail showed the company acting responsibly.
  • Current kratom consumers described the bottle as more professional than the kratom products they consume today.

The research was designed to inform further label improvements.

Botanic Tonics’ Position

Consumers deserve to know what is in a product and what the evidence says about it. Natural kratom leaf and concentrated synthetic 7-OH are different products with different risk profiles, and the federal agencies that have addressed them draw that line. Treating them as one category confuses the public and makes it harder to protect people from the products that cause the most harm.

As feel free CLASSIC reaches more retailers and more adult consumers, Botanic Tonics is growing in a transparent and responsible way, with clear labeling that supports informed choices. Botanic Tonics leads the industry in consumer education and transparency and will continue to work with regulators, researchers, and public health officials.

Supporting Sources

[1] Peer-reviewed clinical safety study (December 2024): “The Safety of Multiple-Dose Liquid Blend Containing Kava and Kratom in Healthy Adults,” Cureus (ISRCTN17198496)

[2] FDA-commissioned pilot study (February 2024): Preliminary results presentation

[3] Human clinical trials catalog: Global Kratom Coalition, “18 Human Clinical Trials”

About Botanic Tonics

Botanic Tonics is the leader in botanical supplements. Founded in 2020 and headquartered in Broken Arrow, Oklahoma, the company's feel free® product line harnesses the wisdom of ancient botanical traditions to support energy, focus, and mood. Its flagship product, feel free® CLASSIC, combines noble kava root and natural kratom leaf in a formulation that contains no synthetic ingredients, alcohol, or chemical extracts and is intended for responsible consumption by adults 21 and older. Its KavaMaté product delivers botanical pairings that provide sustained, grounded energy without the jitters associated with artificial energy drinks. With hundreds of millions of servings sold, feel free® CLASSIC is produced in accordance with strict manufacturing and quality standards, supported by independent batch testing and peer-reviewed research. Botanic Tonics’ products are manufactured in an FDA-registered, cGMP-certified facility and undergo multiple tests for consistency and safety. Botanic Tonics continues to lead the energy and supplement category in education and transparency through extensive consumer education. Learn more at botanictonics.com.

Disclaimer

The statements in this press release have not been evaluated by the U.S. Food and Drug Administration. The products referenced are not intended to diagnose, treat, cure, or prevent any disease. This announcement is provided for informational purposes only and does not constitute medical advice.

Warning and Caution

feel free CLASSIC can be habit-forming. Consume responsibly. For adults 21 years of age and older only. Do not exceed one serving (half a bottle) at any one time, and do not exceed two servings (one bottle) in a 24-hour period. feel free CLASSIC contains kratom leaf, which, like nicotine and alcohol, can become habit-forming and harmful to your health if consumed irresponsibly. DO NOT USE if you have a history of substance abuse. May interact with certain medications — consult a licensed, qualified health care professional before use. Do not consume with excessive alcohol. Not intended for individuals sensitive to active ingredients or women who are pregnant, nursing, or trying to become pregnant. For more information, visit the Botanic Tonics Consumer Education page.

Media Contact

media@botanictonics.com

November 17, 2026 3:07 PM
EDT
•
BOSTON, MA

Introducing OpenJS Ad Network

BOSTON, MA, November 17, 2026 (EZ Newswire) -- Open source powers much of the web. Keeping it healthy takes more than code. It takes people, infrastructure, security work, governance, and sustainable funding.

Today, we’re announcing the OpenJS Ad Network, an opt-in advertising program that will generate revenue for participating OpenJS projects and the foundation.

The first participants in the OpenJS Ad Network include Node.js, Fastify, Lodash, webpack, and jQuery, along with the OpenJS Foundation's own website. Together, these sites reach developers across the JavaScript ecosystem, creating an opportunity to generate new funding for the projects and communities behind them.

The goal is simple: turn the reach of the websites developers already visit into an opportunity to support the open source technologies they rely on every day.

Advertising that gives back to open source

The OpenJS Ad Network will feature curated advertisements relevant to developers, with privacy at its core. The program will not use behavioral targeting or third-party tracking, helping provide a developer-friendly advertising experience.

Participation is entirely optional. Each project can decide whether to join the network and where the ad units appear, maintaining control over its own experience and community.

BuySellAds operates and sells the network, and OpenJS reviews and approves advertisers. It follows the same model BuySellAds runs for Mozilla Developer Network (MDN).

Building a more sustainable future for open source

For OpenJS, a key part of the model is sharing the revenue with participating projects. That creates a direct funding stream for the projects and maintainers whose websites make the network possible, while also supporting the shared infrastructure and services provided by the foundation.

There is no single solution to open source sustainability. A healthy ecosystem needs diverse funding sources, including corporate memberships, sponsorships, grants, services, and innovative models such as advertising.

A more diverse funding model can make open source more resilient, alongside greater financial support from the companies that depend on these projects and infrastructure every day.

The OpenJS Board has approved the program with support from the OpenJS Cross Project Council, and we’re now beginning to work with projects that choose to participate.

Advertisers interested in reaching JavaScript developers can contact BuySellAds.

Together, we can turn the reach of the JavaScript ecosystem into another resource for sustaining the open source projects we all depend on.

About BuySellAds

BuySellAds is an advertising company that has connected brands with engaged, hard-to-reach audiences since 2008. The company operates and sells advertising programs for developer and technology publishers, including MDN, with a focus on contextual, privacy-respecting placements. BuySellAds helps independent publishers and open source projects build sustainable revenue while keeping control of their audience experience. Learn more at buysellads.com.

About OpenJS Foundation

The OpenJS Foundation provides a neutral home for open source JavaScript and web projects, including Node.js, jQuery, webpack, Fastify, and Lodash. The foundation supports its projects with governance, infrastructure, security, and funding programs, working to make the web safe and modern for the many websites that rely on JavaScript. Learn more at openjsf.org.

Media Contact

sam@buysellads.com

November 17, 2026 3:05 PM
EDT
•
WASHINGTON, DC

American Kratom Association Demands CBS '60 Minutes' Correct Major Errors and Explain Why Critical Scientific Evidence Was Omitted

WASHINGTON, DC, November 17, 2026 (EZ Newswire) -- The American Kratom Association (AKA) today demanded substantial corrections, an editorial review, and a meaningful on-air response to the Nov. 15 "60 Minutes" broadcast on kratom, charging that the program presented a materially incomplete and misleading account of federal drug policy, forensic science, and the potential benefits and risks of natural botanical kratom.

In an expanded formal letter to CBS News, the AKA identified significant factual errors and omissions that raise serious questions about the credibility and fairness of the broadcast.

“60 Minutes had the actual federal regulatory documents. They had our detailed written responses. They had access to the latest forensic science. Yet viewers received a report that misstated the Drug Enforcement Administration’s threshold, ignored a critical second scheduling requirement, and omitted important evidence that did not fit the program’s narrative,” said Mac Haddow, senior fellow on public policy for the American Kratom Association.

“That is not the level of investigative rigor the public should expect from '60 Minutes.'”

NMS Labs’ Own Advisory Raises Questions About the Broadcast’s Death Claims

One of the AKA’s most serious concerns involves the interview with NMS Labs toxicologist Justin Brower.

Brower told viewers that he had encountered numerous deaths attributed exclusively to kratom.

But the broadcast did not explain NMS Labs’ recently published advisory, "Mitragynine Alone No Longer Tells the Story: Rethinking Kratom Testing."

The advisory warns that older or limited toxicology methods may fail to identify relevant compounds, including 7-hydroxymitragynine (7-OH) and mitragynine pseudoindoxyl (MGPI), potentially affecting the interpretation of kratom-related deaths.

It calls for comprehensive quantitative testing that distinguishes individual alkaloids and accounts for their chemical instability, possible conversion during analysis, and interactions with other substances.

“The laboratory represented as a leading authority in the program has itself published a warning that mitragynine-only testing is no longer sufficient to characterize many kratom-related exposures,” Haddow stated.

“Why wasn’t that critical scientific qualification explained to viewers?”

The AKA acknowledges that it does not know whether Brower’s interview occurred before or after the NMS advisory was published, or whether he discussed those limitations during portions of the interview that did not air.

The association is requesting that CBS clarify those questions.

The omission is particularly significant because the program also interviewed forensic scientist Alex Krotulski, co-author of an October 2026 study documenting serious analytical challenges involving 7-OH, MGPI, and related compounds.

That research found that 7-OH concentrations in refrigerated blood declined by 89% over 112 days, accompanied by increased MGPI concentrations.

“Families deserve accurate conclusions about the deaths of their loved ones. They should not be led to believe that older toxicology results definitively establish natural kratom as the cause when critical compounds may not have been adequately tested,” Haddow said.

The AKA is calling for scientifically justified reassessment of historical cases where inadequate testing or retained evidence raises legitimate questions about the original conclusions.

NIH’s June 1 Announcement Directly Contradicts the Impression That Mitragynine Has No Serious Scientific Therapeutic Potential

The AKA also challenges the broadcast’s failure to report a significant announcement from the National Institutes of Health.

On June 1, 2026, NIH announced that its Investigational New Drug application for purified mitragynine had taken effect with the Food and Drug Administration (FDA), allowing federal researchers to begin Phase I human safety research evaluating the compound as a potential treatment for opioid use disorder.

The broadcast instead presented kratom’s possible role in opioid withdrawal largely as a disputed industry claim and featured Dr. Andrew Kolodny dismissing its therapeutic prospects.

“The federal government’s own scientists are investigating purified mitragynine as a possible opioid use disorder treatment, yet that major development was missing from a national broadcast questioning whether kratom has any legitimate potential benefit,” Haddow said.

“That is an extraordinary omission.”

The AKA emphasizes that the NIH announcement does not establish that mitragynine is effective for opioid use disorder or that FDA has approved kratom as a treatment.

It does, however, demonstrate that NIH considers the compound sufficiently promising for controlled human research following preclinical investigation.

“Viewers deserved to know that this was an active federal scientific research question — not simply a marketing claim made by kratom advocates,” Haddow added.

Why Were Industry Relationships Scrutinized on One Side but Not the Other?

The AKA also questioned the broadcast’s extensive treatment of lobbying expenditures and alleged political influence.

The association disclosed more than $14 million in state and federal lobbying expenditures from 2016 through 2025 in its Nov. 11 response to CBS, explaining that the money supported consumer protection legislation, manufacturing requirements, labeling standards, age restrictions, and continued access to natural botanical kratom.

Yet the program did not present a comparable accounting of lobbying and political activity by manufacturers seeking to preserve the market for concentrated 7-OH products.

Nor did it place the AKA’s expenditures in the context of lobbying throughout the health care industry.

Pharmaceutical and health-products interests spent approximately $452 million on federal lobbying in 2025, according to OpenSecrets-derived data.

“If '60 Minutes' intends to follow the money, it should follow all of the money — not selectively investigate advocacy for natural kratom while overlooking competing commercial interests,” Haddow said.

The association also called for consistent scrutiny of potential economic interests in the addiction treatment and recovery industry, including any relevant relationships between treatment providers, pharmaceutical companies, and experts advocating particular drug-policy positions.

AKA Questions Incomplete Disclosure of Dr. Andrew Kolodny’s Professional and Financial Relationships

The broadcast featured Dr. Andrew Kolodny as a prominent critic of natural kratom but provided limited information about his professional relationships in the addiction treatment field.

Kolodny previously served as chief medical officer of Phoenix House, a national addiction treatment organization. He has supported the development of buprenorphine treatment programs and has served as a paid expert witness in opioid-related litigation.

Those relationships are publicly documented.

The AKA is not asserting that Kolodny has any continued undisclosed financial interest in Suboxone’s manufacturer or in promoting its products. It is asking why his relevant professional and compensated activities did not receive the same degree of examination applied to kratom-associated researchers and advocates.

“Dr. Kolodny is entitled to his opinions. But when '60 Minutes' questions the credibility of people who support natural kratom because of their industry relationships, the program should apply comparable disclosure standards to experts who oppose it,” Haddow said.

“Credibility requires consistent standards, not selective scrutiny.”

CBS Made a Tenfold Error in Describing the DEA Scheduling Proposal

The AKA further identified a clear factual error in the broadcast’s statement that the federal government increased the permitted 7-OH concentration by 20-fold.

The original DEA concentration threshold was 0.5 milligrams per gram. The revised October threshold is 1 milligram per gram.

That is a twofold increase — not 20-fold.

The program also failed to adequately explain that the revised DEA proposal counts 7-OH and MGPI together under a single concentration limit and adds an independent requirement that the ratio of mitragynine to the combined opioid-active compounds must not fall below 100-to-1.

Failure of either proposed requirement would trigger Schedule I controls.

The AKA provided these facts to CBS four days before the broadcast.

“The mathematical error is serious. But the failure to explain the actual two-part scheduling rule is even more consequential because it distorted the public’s understanding of what the federal government proposed,” Haddow said.

Critics Received Extensive Airtime While AKA’s Detailed Written Response Was Reduced to a Passing Reference

CBS contacted the AKA on Nov. 6 with five questions concerning kratom policy, lobbying, and political influence.

The association responded in an eight-page letter on Nov. 11 and expressed interest in participating in an on-air interview.

No such AKA interview appeared in the broadcast.

Instead, critics received extensive speaking opportunities while the AKA’s substantive written response was largely absent.

The program also highlighted Haddow’s decades-old ethics convictions while presenting an edited excerpt of his congressional testimony concerning the absence of an established lethal dose of natural botanical kratom.

The AKA is requesting review of the complete footage and the context of those statements.

“'60 Minutes' questioned our credibility while declining to give viewers a comparable opportunity to hear our explanations directly,” Haddow said.

“When a program directly attacks an organization’s credibility, it should not treat a detailed written response as merely a procedural formality.”

AKA Demands Corrections, an Editorial Review, and an On-Air Opportunity to Respond

The association’s formal letter requests that CBS:

  • Correct the erroneous 20-fold statement and explain the complete DEA scheduling framework.
  • Address NMS Labs’ advisory and the limitations of historical mitragynine-only forensic testing.
  • Explain why NIH’s June 1 announcement concerning mitragynine research was omitted.
  • Review the treatment of lobbying expenditures and the disclosure of relevant relationships involving interview subjects.
  • Clarify the distinction between kratom-associated deaths and deaths proven to involve natural botanical kratom as a causal factor.
  • Publish the AKA’s complete Nov. 11 response and provide a meaningful opportunity for an on-air interview.

The AKA is also requesting that CBS review the broadcast’s characterization of FDA Import Alert 54-15 and the full context of edited statements attributed to its representatives.

“The credibility of '60 Minutes' will ultimately be measured by what it does now that these factual errors and omissions have been brought directly to its attention,” Haddow concluded.

“Families deserve accurate forensic science. Consumers deserve truthful information. Policymakers deserve a complete explanation of federal regulations. And the American public deserves an investigative news program that follows the evidence even when the evidence complicates its narrative.”

“CBS News should correct the record, explain what happened in its editorial review, and demonstrate that '60 Minutes' holds itself to the same standards of accuracy, transparency, and accountability that it demands from everyone else,” Haddow added.

Principal Supporting Sources

About American Kratom Association

The American Kratom Association is a consumer advocacy organization committed to protecting access to safe, natural kratom leaf products and advancing science-based consumer protection standards. The AKA supports age restrictions, accurate labeling, contaminant testing, good manufacturing practices, and strong enforcement against adulterated, mislabeled, synthetic, semi-synthetic, concentrated, fortified, or chemically manipulated products falsely marketed as kratom.

Important Disclosures

The American Kratom Association (AKA) is a 501(c)(4) nonprofit advocacy organization. This press release is issued for informational and public policy purposes only. The information contained herein reflects policy analysis regarding federal administrative actions and does not constitute legal, regulatory, or medical advice. Statements regarding natural kratom leaf products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Readers should consult qualified health care professionals regarding personal medical decisions.

Media Contact

Mac Haddow
Senior Fellow on Public Policy
press@americankratom.org
+1 571-294-5978

November 17, 2026 1:36 PM
EDT
•
LOS ANGELES, CA

SourceX Opens a Direct Licensing Route for Business Data Used in AI Training

LOS ANGELES, CA, November 17, 2026 (EZ Newswire) -- SourceX Inc. (SourceX) is inviting established businesses to assess whether approved operational data they already hold could support AI training and evaluation. The company advertises potential supplier compensation of up to $4 million for the largest enterprise datasets, subject to qualification, rights review, and signed terms.

The invitation focuses on knowledge created through ordinary business operations, including support histories, documented workflows, project records, engineering records, and internal knowledge bases. SourceX seeks to turn an initial assessment of those records into a defined licensing discussion, with each company deciding whether to proceed and what scope it can approve.

Who the program is designed for

Initial screening generally looks for companies with at least 50 full-time employees at peak and several years of operating history. Operating businesses, acquired companies, and businesses winding down may all be considered. The initial fit check for SourceX's enterprise data licensing program asks about the company and its potential records without requiring uploads or a commitment to any transaction.

A direct licensing relationship

Businesses sign with SourceX as their contractual counterparty. SourceX manages qualification, rights review, agreements, data preparation, delivery, and payment.

The $4 million figure is an upper bound for the largest enterprise datasets, not typical or guaranteed compensation. A proposed transaction depends on the records, the rights available, the permitted use, and the terms agreed for that dataset. Not every company or archive will qualify.

Rights, privacy, and security review

Before any licensing, SourceX reviews ownership, customer obligations, employee privacy, and platform restrictions. Access to a business system does not by itself establish permission to license all the information it contains. Companies approve the scope, and data is de-identified before use or onward sharing. De-identification reduces privacy risk but does not eliminate it.

SourceX states that data in its care is encrypted, access-controlled, and logged. A useful operational history may connect a business problem with the actions taken and the resulting outcome, and that context distinguishes a considered dataset from an indiscriminate export. SourceX reviews the relevant sources and preparation route as part of evaluating each potential transaction.

A separate program for advisor introductions

Through refer.sourcex.si, approved partners such as private equity operating partners, M&A advisors, fractional CFOs, accountants, and IT service providers can introduce qualifying companies for a licensing assessment.

Under current standard terms, a partner's first qualifying transaction pays the greater of $50,000 plus 5% of the eligible actual supplier payout, or 15% of that payout. A qualifying transaction generally requires at least $100,000 in eligible supplier compensation unless otherwise agreed in writing.

Rewards are payable only after the qualifying transaction closes, SourceX pays the referred company, and finance approval, tax, and payment details are in place. A signup, lead, meeting, or supplier agreement alone does not earn a reward. The supplier and partner programs have separate qualification and contractual requirements.

Getting started

The assessment gives leadership a practical place to start: identify the records under company control, consider the business context they preserve, and establish who can authorize a review. Participation begins with a fit discussion, with transaction details agreed separately in writing. SourceX is seeking discussions with business owners and authorized decision-makers who can assess relevant company records and the rights attached to them.

About SourceX

SourceX, headquartered in Los Angeles, licenses approved business data directly from companies for AI training and evaluation. It manages qualification, rights review, agreements, data preparation, delivery, and payment, and operates a referral program for qualifying company introductions.

About Noah Loul

Noah Loul is the founder and CEO of SourceX. He previously founded B2B Rocket, an AI sales automation company acquired by Blackpearl Group in 2025.

Disclaimers and Program Terms

The compensation and referral figures in this release, including the $4 million supplier upper bound, represent maximums or illustrative examples only and do not reflect typical, average, or guaranteed earnings. Actual payouts depend on dataset quality, verified intellectual property rights, buyer demand, and executed written contracts; many applicants and referrals will not qualify. SourceX's qualification and de-identification reviews do not constitute legal or regulatory compliance advice, and participating companies remain solely responsible for ensuring their right to license data under applicable privacy laws and third-party agreements. Program terms, thresholds, and reward structures are governed by separate written agreements and are subject to change. This release contains forward-looking statements.

Media Contact

Sarelle London
sarelle@sourcex.si

November 17, 2026 12:28 PM
EDT
•
LONDON, United Kingdom & ISTANBUL, Türkiye & NEW YORK, NY

Dr. Cinik Dental Announces London-Based Consultations and Follow-Up for UK Patients Considering Treatment in Turkey

LONDON, United Kingdom & ISTANBUL, Türkiye & NEW YORK, NY, November 17, 2026 (EZ Newswire) -- Dr. Cinik Dental, an Istanbul-based dental clinic, announced that its London practice supports UK patients before and after dental treatment in Turkey carried out at its facilities in Istanbul or Antalya. The clinic said the model is intended to address continuity-of-care concerns associated with dental tourism by allowing patients to receive an in-person assessment in the UK before travel and to attend follow-up appointments after returning home.

According to the clinic, the pathway is structured so that the patient's first clinical contact and later review appointments can take place in the UK, while the main procedure is carried out abroad. The clinic also said this approach is relevant for patients who want face-to-face guidance before committing to travel and a local point of contact if concerns arise during recovery.

Why continuity of care is part of the discussion

Dental treatment in Turkey has become a recurring topic in UK public debate, particularly where patients return home and then need review, adjustment or urgent assessment. The concerns raised are not limited to whether treatment abroad can be clinically appropriate. They also include what happens when a patient needs help after the procedure, whether records are available, and whether a local dentist can identify the materials and components used.

The discussion around so-called "Turkey teeth" has also drawn attention to overtreatment, limited aftercare and the difficulty some patients face when seeking help close to home. Dr. Cinik Dental said its UK-based consultations and follow-up appointments are intended to reduce some of the practical barriers associated with that gap. The clinic cautioned that no care model can remove risk entirely and that suitability for treatment still depends on individual examination, medical history, oral health and informed consent.

Initial assessment in the UK

Under the pathway described by the clinic, prospective patients may attend screening and examination days in selected UK cities or book a consultation at the London practice. Patients comparing options after looking for a free dental consultation in London should confirm what the appointment includes, whether any cost applies and what records will be provided. The clinic said these appointments are used to review oral health, discuss suitability and outline possible treatment options before any travel is arranged.

In general terms, an in-person dental assessment may include a review of the teeth and gums, an examination of bite and jaw function, a discussion of symptoms and treatment goals, and imaging where clinically indicated. The clinic said that assessments carried out in person can provide information that is difficult to confirm through photographs or video calls alone, including gum condition, signs of infection, bone support and the stability of existing dental work.

Treatment in Istanbul or Antalya

Treatment is carried out in Istanbul or Antalya after the initial UK assessment. In relevant cases, the clinic said dental implants in Istanbul may be planned using implant systems from manufacturers including Straumann and Nobel Biocare. It added that implant selection varies according to clinical need, availability and the treating clinician's judgment.

The clinic said that patients receiving implant treatment should be given information about the system used, including the brand, component type and any documentation needed for future maintenance. It said this information can be important if a patient later seeks review or repair in another country.

Follow-up and dental aftercare in the UK

After patients return to the UK, follow-up appointments are available at the London practice, according to the announcement. The clinic said this structure is intended to connect overseas treatment with dental aftercare in the UK, so that healing can be reviewed and concerns can be assessed without requiring the patient to travel back immediately.

The clinic said follow-up care may involve checking soft-tissue healing, reviewing oral hygiene, assessing discomfort or swelling, and deciding whether further imaging or referral is needed. It added that patients experiencing severe pain, uncontrolled bleeding, signs of infection or other urgent symptoms should seek prompt local medical or dental care rather than waiting for review.

What patients should confirm before treatment

Patients considering treatment abroad are advised to confirm the clinician's qualifications, ask which implant systems may be used, review the risks and limitations of the proposed procedure, and establish what aftercare is available in the UK before making a decision.

About Dr. Cinik Dental

Dr. Cinik Dental is an Istanbul-based dental clinic with facilities in Istanbul and Antalya and a practice in London. According to the clinic, it provides dental consultations, treatment planning, implant and restorative procedures, and follow-up care for UK and international patients. For more information, visit cinikdental.com.

Disclaimer

This announcement was issued by Dr. Cinik Dental. It is intended for information only and is not a substitute for assessment, diagnosis or advice from a qualified dental professional.

Media Contact

Serkan Kaya
Performance Marketing Manager
press@emrahcinik.com

November 17, 2026 12:23 PM
EDT
•
KILMARNOCK, VA

David L. Nickel Joins Ann Partners to Lead Broadcloth Wealth & Partners

KILMARNOCK, VA, November 17, 2026 (EZ Newswire) -- David L. Nickel joined Ann Partners as a partner in August 2025 and now runs Broadcloth Wealth & Partners, his own registered investment advisory practice, under the national firm's umbrella. As founder and managing director, Nickel manages client accounts from his Kilmarnock office, commuting from his home 100 miles away three days a week, and works the rest of the week remotely.

Move to a Hybrid Partnership

Ann Partners formed two or three years ago when former Wheat First Securities colleagues came together. Its founder, whom Nickel has known for decades, had grown tired of Wells Fargo, as Nickel had. “The company is growing rapidly, which we're very happy about,” Nickel said.

The hybrid model lets Nickel keep his own advisory firm within the larger company. Trades clear through Fidelity, which provides support, compliance, and administrative services, so he doesn’t need his own resources division.

Career Path From Banking to Securities

On Oct. 19, 1987, the day of the stock market crash, Nickel entered the securities business. He had spent about a decade as a banker, first at Bank of Lancaster and then at Bank of Virginia, which later became part of Signet Banking Corporation and eventually First Union Corporation.

Nickel began at Wheat First Securities, a small regional firm, and later worked at Wells Fargo Advisors. He holds a bachelor's degree in history with a business minor from the University of Richmond. “With a history degree and a financial background, I look at history to understand where we are and where to guide my clients’ assets,” he explained.

Investment and Tax Approach

Buying what everyone is talking about is more fun. However, Nickel stated, “Sometimes you have to buy things that are out of favor.” He keeps those holdings to a small part of a portfolio because they may perform well later.

Nickel looks for quality stocks that grow clients’ income while limiting the taxes they pay. Bonds make up only 2% or 3% of his portfolio, and he uses a 90/10 stock-to-bond mix with his oldest clients instead of the traditional 60/40 split. He also realizes tax losses to offset gains, which lets clients stay invested without panicking.

Tax treatment varies by income type and individual circumstances. Bond income is taxed at a client’s full tax rate, while dividends are taxed at the lower capital gains rate. Nickel uses covered-call funds, which sell options on the stocks they hold to generate income taxed at the full rate.

For example, he pairs $10,000 in Microsoft with $5,000 in QQQI, a covered-call fund yielding about 11%. Nickel puts the combined yield near 4%, with more room for growth from Microsoft. The example reflects his approach and is not advice for any individual.

Views on AI and Research Tools

Nickel supports using artificial intelligence. He acknowledged AI could turn ugly but said guardrails exist and its creators should remain accountable.

“I'm looking forward to AI because I use it now,” he shared. “I have about 20 research sources, and one of the best tools I use lets me see every analyst's ranking and price target for a stock.”

The tool lets him compare many views instead of relying only on what Wells Fargo promotes.

Plans for the Next Five Years

Nickel plans to keep expanding the practice and add another person for client coverage, and he has no plans to retire. As a registered investment advisor, he must meet clients at least once a year. He typically meets them quarterly and sometimes monthly, and about 90% of those meetings take place in clients’ homes.

About Broadcloth Wealth & Partners

Broadcloth Wealth & Partners is a registered investment advisory practice based in Kilmarnock, Virginia. It operates under the Ann Partners umbrella, serves clients nationwide, and clears trades through Fidelity.

About Marquis Who's Who

Since 1899, when A. N. Marquis printed the first edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field, including politics, business, medicine, law, education, art, religion, and entertainment. Who's Who in America remains an essential biographical source for thousands of researchers, journalists, librarians, and executive search firms worldwide. The suite of Marquis® publications can be viewed at the official Marquis Who's Who® website, marquiswhoswho.com.

Media Contact

info@marquiswhoswho.com